Bilcare Quarterly Results for Trading Insights

BI • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-23 Cr
QSept 2025
Quarterly Results

Bilcare Quarterly Results Key Highlights

  • Revenue of ₹183 Cr in Sept 2025 (-14.9% vs Mar 2025, -11.2% vs Sept 2024)
  • Net Profit of ₹-23 Cr in Sept 2025 (-560.0% vs Mar 2025, +23.3% vs Sept 2024)
  • EBITDA of ₹8 Cr in Sept 2025 (-72.4% vs Mar 2025)
  • Operating Margin of 2.0% in Sept 2025 (-2.0pp vs Mar 2025)
  • Earnings Per Share of ₹-5.25 in Sept 2025 (-217.2% vs Mar 2025)

Bilcare Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 183 215 192 187 206 -14.9% -11.2%
Net Profit (₹ Cr) -23 5 -10 -13 -30 - -
EBITDA (₹ Cr) 8 29 17 16 2 - -
EPS (₹) -5.25 4.48 -1.61 -2.53 -6.81 - -
Operating Margin (%) 2.0% 4.0% 6.0% 6.0% -1.0% - -

Bilcare Share Price Trend Around Quarterly Results

Visualize Bilcare's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Bilcare

Additional stock information and data for BI

Bilcare share price today
BI price earnings ratio
BI yearly price range

Profitability Ratios

Profit Margin -12.6%
EBITDA Margin 4.4%
Operating Margin 2.0%
ROE (Annual) -15.6%

Balance Sheet Highlights

Total Assets ₹1,417 Cr
Total Equity ₹590 Cr
Current Assets ₹343 Cr
Current Liabilities ₹488 Cr

Cash Flow Analysis

Operating Cash Flow ₹63 Cr
Investing Cash Flow ₹-106 Cr
Financing Cash Flow ₹36 Cr
Net Cash Flow ₹-8 Cr

Current Market Data

Current Price ₹52.76
Exchange BSE
Last Updated Mar 30, 2026

Revenue Trend (₹ Cr)

Dec 2025 187
Jun 2025 192
Mar 2025 215
Sept 2025 183

Net Profit Trend (₹ Cr)

Dec 2025 -13
Jun 2025 -10
Mar 2025 5
Sept 2025 -23

Operating Margin Trend (%)

Dec 2025 6.0%
Jun 2025 6.0%
Mar 2025 4.0%
Sept 2025 2.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Bilcare quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹430,344.72 Cr 1757.2 14,875 3,125 +10.8% - 21.0% 135.2
Divis Laboratories
Sept 2025 		₹159,214.78 Cr 5947.0 2,860 689 +7.1% - 24.1% 229.0
Torrent Pharmaceuti…
Sept 2025 		₹144,367.29 Cr 4220.2 3,219 591 +11.3% - 18.4% 240.6
Lupin
Sept 2025 		₹107,238.09 Cr 2313.9 6,921 1,485 +23.2% - 21.5% 71.5
Dr Reddys Laborator…
Sept 2025 		₹106,974.57 Cr 1254.9 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores